Drug Development and healthcare technology

Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

Digital Health Global

APRIL 25, 2024

About Koneksa Koneksa is a healthcare technology company pioneering evidence-based digital biomarkers to accelerate clinical research and guide decision-making in drug development and market strategy. These adverse events often lead to hospitalizations and treatment interruptions that can reduce treatment efficacy.

Health Data

Health Data BioTech Drug Development healthcare technology

Merative formerly IBM Watson Health poised to launch raft of new products in 2025

Lloyd Price

NOVEMBER 16, 2024

With significant investments and a focus on innovation, Merative is poised to play a major role in shaping the future of healthcare data analytics and technology. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Drug Development

Drug Development healthcare technology Leadership Life Science

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

Digital Health Global

MARCH 2, 2023

As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development.

Life Science

Life Science Drug Development BioTech Leadership

Webinars

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Less Stress, More Success: Accounting Best Practices & Processes for 2025

MORE WEBINARS

Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers

Digital Health Global

JUNE 13, 2023

“The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights.

Drug Development

Drug Development eMed BioTech Digital Health

Key Themes from the Morgan Stanley 22nd Annual Global Healthcare Conference 2024

Lloyd Price

SEPTEMBER 16, 2024

The conference explored the advancements in precision medicine and its implications for healthcare delivery. Biopharma Innovation and Drug Development: The development of innovative drugs and therapies remains a key focus in the healthcare industry.

Digital Health

Digital Health Drug Development healthcare technology Leadership

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

NOVEMBER 21, 2023

By implementing these strategies, Palantir can effectively address public concerns, build trust, and gain acceptance for its role in delivering the NHS Federated Data Platform, ultimately contributing to improved patient care and healthcare outcomes in England. What are a few likely scenarios for Palantir in Healthcare?

Drug Development

Drug Development Health science healthcare technology Leadership

HLTH 2024: What are the key talking points likely to be?

Lloyd Price

OCTOBER 14, 2024

Overall, HLTH 2024 is expected to be a thought-provoking and informative event that will shape the future of healthcare. Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value.

Leadership

Leadership healthcare technology Digital Health Mental health

HealthTech M&A 2025 Predictions: Europe and USA

Lloyd Price

NOVEMBER 8, 2024

The increasing adoption of digital health technologies, the growing importance of AI and ML, and the evolving regulatory landscape will continue to shape the deal landscape. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Digital Health

Digital Health healthcare technology Pharmaceuticals Telehealth

PicnicHealth Acquires AllStripes, Fortifying its Role as the Leader in Patient-Centered Healthcare Evidence Generation

Healthcare IT Today

NOVEMBER 6, 2023

About AllStripes ‍ Founded in 2017, AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. To learn more about why 80% of the top Biopharma companies partner with PicnicHealth or to view our 35+ publications, visit picnichealth.com.

Life Science

Life Science Drug Development Patient Experience healthcare technology

Clinical Value of Digital Phenotyping in Mental Health

Lloyd Price

AUGUST 3, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Drug development: Assessing treatment efficacy and patient adherence.

Mental health

Mental health Pain management Drug Development Leadership

Koneksa Announces New Multi-Domain Model for Functional Status Assessment Enabled by Digital Health Technologies

Digital Health Global

JANUARY 4, 2024

Our evidence-based biomarker solutions enable efficient clinical trial designs to help innovative therapies reach patients faster.

Health Technology

Health Technology Digital Health Drug Development healthcare technology

Taker-Shaper-Maker model and Future of Generative AI in Healthcare

Lloyd Price

APRIL 27, 2024

Exec Summary: Generative AI is a powerful new tool with the potential to revolutionize healthcare. It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. But how can healthcare organisations best leverage this technology? Visit www.nelsonadvisors.co.uk

healthcare technology

healthcare technology Leadership Drug Development Digital Health

Nvidia spends $1 Billion acquiring Two Israeli AI startups with massive HealthTech and Healthcare AI potential

Lloyd Price

MAY 2, 2024

Digital Biology: Tools like BioNeMo utilise AI to analyse vast amounts of biological data, leading to breakthroughs in drug development and understanding of diseases. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Visit www.nelsonadvisors.co.uk

healthcare technology

healthcare technology Drug Development Leadership Digital Health

Chief AI Officers in Healthcare: CAIO's emerging now with a big future ahead

Lloyd Price

MAY 30, 2024

However, these early successes provide a promising outlook for the role and its potential to revolutionise healthcare with the responsible use of AI. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Leadership

Leadership healthcare technology Interoperability Drug Development

European Parliament approves creation of the European Health Data Space: unified system for managing electronic health data across member states

Lloyd Price

APRIL 29, 2024

Boost research and innovation: Researchers will have a secure platform to access and analyse large datasets for medical research, leading to advancements in disease prevention, treatment, and drug development. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Health Data

Health Data healthcare technology Digital Health Leadership

Neuralink, Brain Computer Interfaces and Neuroscience innovation primed for mainstream growth in 2025

Lloyd Price

OCTOBER 9, 2024

Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Mental health

Mental health healthcare technology Leadership Digital Health

Machine Learning and Computational Algorithms are revolutionising Diagnostics and attracting significant HealthTech M&A interest

Lloyd Price

APRIL 22, 2024

Growing Market: The global market for AI in healthcare is projected to reach astronomical figures in the coming years, reflecting the confidence in this technology. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Visit www.nelsonadvisors.co.uk

healthcare technology

healthcare technology Leadership Drug Development Digital Health

What can Healthcare AI learn from Weather AI?

Lloyd Price

MAY 6, 2024

By incorporating the strengths of weather AI, healthcare AI can become even more powerful in predicting, preventing, and managing health issues, leading to a more personalised and proactive healthcare system. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

healthcare technology

healthcare technology Leadership Drug Development Digital Health

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

FEBRUARY 18, 2024

AI and machine learning: Companies with advanced AI solutions for tasks like drug discovery, clinical trial optimisation, and personalised medicine can be attractive targets. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pharmaceuticals

Pharmaceuticals healthcare technology Digital Health Remote care

Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares

Lloyd Price

FEBRUARY 18, 2024

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pharmaceuticals

Pharmaceuticals healthcare technology Leadership Drug Development

Medical Record Automation: MRA emerges as one of the key HealthTech sub sectors in 2024

Lloyd Price

AUGUST 7, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Interoperability

Interoperability Leadership EHR Drug Development

The 4 Big Gaps in HealthTech: Funding, Trust, Evidence, Valuation

Lloyd Price

OCTOBER 28, 2024

Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Interoperability

Interoperability healthcare technology HIPAA Leadership

Self-sovereign identity (SSI) - the future of Health Data?

Lloyd Price

FEBRUARY 2, 2024

Benefits for healthcare stakeholders: Streamlined patient onboarding: Verifiable credentials from SSI wallets can expedite patient registration and verification, reducing administrative burdens and improving wait times.

Health Data

Health Data Interoperability healthcare technology Leadership

Digital Health v HealthTech: What is the difference?

Lloyd Price

JULY 15, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Digital Health

Digital Health Mobile Health Telehealth Leadership

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

Lloyd Price

FEBRUARY 22, 2024

Overall, the pain management market is poised for significant growth, fuelled by technological innovation and a growing demand for effective, non-opioid solutions. Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Pain management

Pain management Mental health Telehealth healthcare technology

Turbine Upsizes its Series A Round to €25.5 Million and Appoints Seasoned Independent Directors to its Board

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development.

BioTech

BioTech Life Science Leadership Drug Development

The Future of Co-Pilots in HealthTech: A Collaborative Revolution

Lloyd Price

SEPTEMBER 6, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Leadership

Leadership Drug Development healthcare technology Digital Health

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Healthcare IT Today

NOVEMBER 14, 2022

Technology investments focus on business and healthcare technology, targeting those ideas with quantifiable development risk and a rapid path to market. Animal Health investments focus on disruptive technologies that have a meaningful impact on global animal health and animal agriculture.

Life Science

Life Science HIPAA Drug Development healthcare technology

Sovereign Health Fund: time to unlock the potential £5Bn ARR asset based on unique NHS datasets?

Lloyd Price

AUGUST 9, 2023

Exec Summary: The concept of a UK sovereign health fund based on NHS data is still in its early stages of development, but it has the potential to revolutionize the way healthcare is funded and delivered in the UK. The global drug development market is estimated to surpass $100bn by 2027. The value lies in sharing safely."

healthcare technology

healthcare technology Healthcare Innovation Drug Development Health Data

10 Key Variables in HealthTech M&A valuation multiples

Lloyd Price

SEPTEMBER 29, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Leadership

Leadership Drug Development healthcare technology Digital Health

Unveiling the Transformative Power: Benefits of AI in Healthcare in 2024

DrKumo Remote Patient Monitoring

FEBRUARY 29, 2024

Ethical guidelines and regulatory frameworks must be established to govern the responsible and ethical use of AI in healthcare, safeguarding patient rights and ensuring equitable access to AI-driven healthcare technologies. What are the benefits of AI in drug development?

Mental health

Mental health Health Data Drug Development Patient Experience

A guide to connected health device and remote patient monitoring vendors

Healthcare IT News - Telehealth

MAY 6, 2020

iRhythm Technologies. iRhythm is a healthcare technology company that clinically diagnoses cardiac arrhythmias by combining wearable biosensing technology with cloud-based data analytics and machine learning capabilities.

Connected Health

Connected Health Telehealth Pharmaceuticals EHR

How Technology Can Help Us Achieve Health Equity

Healthcare IT Today

MAY 5, 2023

Whereas a traditional visit to the doctor can analyze one’s physical health in a fixed time, technology can gather data throughout a patient’s lived experiences, helping healthcare professionals understand patient backgrounds, experiences, and personal preferences on a deeper level. Tanja Dowe, CEO of Debiopharm Innovation Fund S.A.

Drug Development

Drug Development Primary Care Remote care Patient Experience

Zephyr AI Raises $111 Million in Series A Financing

Healthcare IT Today

APRIL 25, 2024

Second, leveraging recent breakthroughs in representation learning, the technology elucidates the biological context underlying its predictions. About Zephyr AI Zephyr AI is a high-growth healthcare technology company committed to radically reshaping precision medicine in oncology and cardiometabolic disease.

Drug Development

Drug Development healthcare technology Health IT Healthcare IT

Connected Health Pulse

Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

Merative formerly IBM Watson Health poised to launch raft of new products in 2025

Webinars

Trending Sources

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

Webinars

Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers

Key Themes from the Morgan Stanley 22nd Annual Global Healthcare Conference 2024

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

HLTH 2024: What are the key talking points likely to be?

HealthTech M&A 2025 Predictions: Europe and USA

PicnicHealth Acquires AllStripes, Fortifying its Role as the Leader in Patient-Centered Healthcare Evidence Generation

Clinical Value of Digital Phenotyping in Mental Health

Koneksa Announces New Multi-Domain Model for Functional Status Assessment Enabled by Digital Health Technologies

Taker-Shaper-Maker model and Future of Generative AI in Healthcare

Nvidia spends $1 Billion acquiring Two Israeli AI startups with massive HealthTech and Healthcare AI potential

Chief AI Officers in Healthcare: CAIO's emerging now with a big future ahead

European Parliament approves creation of the European Health Data Space: unified system for managing electronic health data across member states

Neuralink, Brain Computer Interfaces and Neuroscience innovation primed for mainstream growth in 2025

Machine Learning and Computational Algorithms are revolutionising Diagnostics and attracting significant HealthTech M&A interest

What can Healthcare AI learn from Weather AI?

Where are HealthTech's soft landing M&A deals in today's market?

Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares

Medical Record Automation: MRA emerges as one of the key HealthTech sub sectors in 2024

The 4 Big Gaps in HealthTech: Funding, Trust, Evidence, Valuation

Self-sovereign identity (SSI) - the future of Health Data?

Digital Health v HealthTech: What is the difference?

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

Turbine Upsizes its Series A Round to €25.5 Million and Appoints Seasoned Independent Directors to its Board

The Future of Co-Pilots in HealthTech: A Collaborative Revolution

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Sovereign Health Fund: time to unlock the potential £5Bn ARR asset based on unique NHS datasets?

10 Key Variables in HealthTech M&A valuation multiples

Unveiling the Transformative Power: Benefits of AI in Healthcare in 2024

A guide to connected health device and remote patient monitoring vendors

How Technology Can Help Us Achieve Health Equity

Zephyr AI Raises $111 Million in Series A Financing

Stay Connected